李 英,董 良,李海金.非小细胞肺癌血清VEGF、bFGF和TNF-α的临床意义[J].肿瘤学杂志,2013,19(1):50-54. |
非小细胞肺癌血清VEGF、bFGF和TNF-α的临床意义 |
The Clinical Significance of Serum VEGF,bFGF and TNF-?琢 in Non-small Cell Lung Cancer |
投稿时间:2012-09-10 |
DOI:10.11735/j.issn.1671-170X.2013.01.B2012450 |
|
|
中文关键词: 癌,非小细胞肺 血管内皮生长因子 碱性成纤维细胞生长因子 肿瘤坏死因子α |
英文关键词:carcinoma,non-small cell lung vascular endothelial growth factor basic fibroblast growth factor tumor necrosis factor-a |
基金项目:浙江省医学会临床科研基金项目(2009ZYC43) |
|
摘要点击次数: 2099 |
全文下载次数: 1000 |
中文摘要: |
摘 要: [目的] 观察非小细胞肺癌(NSCLC)患者血清血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF)和肿瘤坏死因子a(TNF-a)与NSCLC临床特征的相关性,探讨三者在NSCLC疗效评价中的临床价值。[方法] 采用双抗体夹心酶联免疫吸附法(ELISA)检测NSCLC患者化疗前1d、化疗结束1周后血清VEGF、bFGF和TNF-a的含量。 [结果] NSCLC患者化疗前血清VEGF、bFGF和TNF-a与患者临床分期有关(P<0.05),与患者年龄、性别及病理类型无关;分析68例晚期NSCLC患者化疗前后血清VEGF、bFGF和TNF-a的变化,临床获益组与疾病进展组比较三者均有明显下降(P<0.05)。[结论] 血清VEGF、bFGF和TNF-a与NSCLC肿瘤负荷有关;血清VEGF、bFGF和TNF-?琢水平可作为NSCLC患者化疗疗效预测的参考指标。 |
英文摘要: |
Abstract:[Purpose] To investigate the levels of serous vascular endothelial growth factor (VEGF),basic fibroblast growth factor (bFGF),and tumor necrosis factor-a (TNF-a) in patients with non-small cell lung cancer(NSCLC) and their relationships with clinical characteristics,and their clinical significance in the evaluation of treatment outcomes were studied.[Methods] The levels of serous VEGF,bFGF and TNF-a were detected by enzyme-linked immunosorbent assay (ELISA) in NSCLC patients before chemotherapy and one week after chemotherapy. [Results] Serous VEGF,bFGF and TNF-a before chemotherapy were correlated with clinical stage(P<0.05),but not with age,gender and pathological type. Among 68 patients with advance NSCLC,the levels of serous VEGF,bFGF and TNF-a declined significantly after chemotherapy in clinical benefit patients than those in patients with progressive disease (PD) (P<0.05). [Conclusion] Serous VEGF,bFGF and TNF-a are related to the cancer load in NSCLC patients. Serous VEGF,bFGF and TNF-a might be helpful in predicting of chemotherapeutic response. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |